The effect of age on hypertension control and management.

[1]  D. Berlowitz,et al.  Identifying Hypertension-Related Comorbidities From Administrative Data: What's the Optimal Approach? , 2004, American journal of medical quality : the official journal of the American College of Medical Quality.

[2]  D. Berlowitz,et al.  Can we use automated data to assess quality of hypertension care? , 2004, The American journal of managed care.

[3]  D. Berlowitz,et al.  Hypertension control: how well are we doing? , 2003, Archives of internal medicine.

[4]  C. Bulpitt,et al.  Results of the pilot study for the Hypertension in the Very Elderly Trial , 2003, Journal of hypertension.

[5]  Ihab Hajjar,et al.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. , 2003, JAMA.

[6]  J. Goodwin.  Embracing complexity: A consideration of hypertension in the very old. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  J. Michel,et al.  Commentary on "Embracing complexity: A consideration of hypertension in the very old". , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[8]  W. Aronow.  Commentaries on “Embracing Complexity: A Consideration of Hypertension in the Very Old” and Author's Response Commentary , 2003 .

[9]  R. Hajjar.  Commentary on "Embracing complexity: A consideration of hypertension in the very old". , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[11]  C. Reid,et al.  A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. , 2003, The New England journal of medicine.

[12]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[13]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[14]  T. Lumley,et al.  Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study. , 2002, Archives of internal medicine.

[15]  B. Davis,et al.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). , 2002, Journal of clinical hypertension.

[16]  L. Kazis,et al.  Identifying patient and physician characteristics that affect compliance with antihypertensive medications , 2002, Journal of clinical pharmacy and therapeutics.

[17]  A. Chobanian.  Control of hypertension--an important national priority. , 2001, The New England journal of medicine.

[18]  K. Bailey,et al.  P-607: The effect of increasing age on hypertension control rates , 2001 .

[19]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[20]  J. Manson,et al.  Hypertension and Its Treatment in Postmenopausal Women: Baseline Data from the Women’s Health Initiative , 2000, Hypertension.

[21]  V. Pavlik,et al.  Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. , 2000, Archives of internal medicine.

[22]  P. Whelton,et al.  Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. , 2000, Hypertension.

[23]  Karla Kerlikowske,et al.  Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials , 1999, The Lancet.

[24]  D. Berlowitz,et al.  Profiling outcomes of ambulatory care: casemix affects perceived performance. , 1998, Medical care.

[25]  C. Bulpitt,et al.  Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial , 1985, The Lancet.

[26]  H. Ward,et al.  Inadequate management of blood pressure in a hypertensive population. , 1999, New England Journal of Medicine.

[27]  Detection.  The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[28]  R. Weinshilboum,et al.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.

[29]  A. D. White,et al.  Isolated systolic hypertension in the elderly: survey of practitioners' attitude and management. , 1993, Gerontology.

[30]  W. Applegate.  Systolic hypertension in older persons. , 1992, Advances in internal medicine.

[31]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.

[32]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.